Abstract:Objective To study the efficacy and adverse effects of quetiapine and risperdal in the long-term treatment of patients with first-episode schizophrenia.Methods This was an open-label case-control study.Two hundred sixty two patients with first-episode schizophrenia met the diagnostic criteria of ICD-10 were recruited.Patients were randomly divided into two groups with 131 patients in each group which received either quetiapine or risperdal for 12 months.The rate of all-cause treatment discontinuation and time to discountinuation and the rate of reduction in Positive and Negative Syndrome Scale(PANSS) was evaluated.The rate of reduction in PANSS score≥50% was defined as much imporved,<50% and ≥25% was improved,and <25% was no change.Treatment Emergent Symptom Scale(TESS),Rating Scale for Extrapyramidal Side Effects(RSESE) and Abnormal Involuntary Movement Scale(AIMS) were performed to evaluate adverse effects.Results ①The rate of treatment discontinuation of quetiapine and risperdal groups were 33.6% and 35.2%,respectively.The duration of treatment of quetiapine and risperdal groups were(9.49±3.83) and(9.52±3.84) months respectively.The duration to relapse of quetiapine and risperdal groups were(3.29±2.34) and(5.11±2.77) months,respectively.There were no significant differences in the rate of treatment discontinuation,the duration of treatment and the duration to relapse between two groups(P>0.05).②The response rates at the end of 2,6,12 months were 78.6%(103/131),86.2%(13/131) and 89.3%(117/131) in quetiapine group,and 82.4%(108/131),87.7%(115/131) and 85.5%(112/131) in risperdal group,respectively.The global efficacy of quetiapine was similar to that of risperdal(P>0.05).③Adverse effects: The rate of extrapyramidal side effects induced by risperdal,such as akathisia,muscle rigidity and tremor,was higer than that of quetiapine(X2=14.94,P<0.05).The rate of dizziness induced by quetiapine was higer than that of risperdal(X2=10.08,P<0.05).Conclusions Both quetiapine and risperdal are effective in the acute phase of first-episode schizophrenia as well as long-term treatment.The efficacy of quetiapine is similar to that of risperdal.Although there is significant difference in the adverse effects between quetiapine and risperdal.

Safety evaluation of iloperidone and risperidone in the treatment of schizophrenia

Efficacy and Safety of Long-Acting Risperidone on Early Onset Schizophrenia in Adolescent Patients

A double blinded multicenter clinical trial for evaluating the efficacy and safety of aripiprazole and risperidone in the treatment of schizophrenia

Paliperidone Extended Release Versus Olanzapine in Treatment-Resistant Schizophrenia

Paliperidone Extended Release Versus Olanzapine in Treatment-Resistant Schizophrenia A Randomized, Double-Blind, Multicenter Study

Risperidone Versus Haloperidol in the Treatment of Acute Exacerbations of Chronic Inpatients with Schizophrenia: a Randomized Double-Blind Study

Study on Efficacy and Safety of Risperidone in Treatment of Different Kinds of Schizophrenia

Double-blind,double-dummy and randomized controlled study of aripiprazole in the treatment of acute schizophrenia

Efficacy and Safety of the Domestic Risperidone in Patients with Schizophrenia:a Randomized,Double-blind,Controlled Trial

Comparison the clinical effects and safety of amisulpride and risperidone in the treatment of schizophrenia

Efficacy and Safety of Iloperidone in Bipolar Mania

Comparison of efficacy after adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia between different gender

Randomized, Double-Blind, 6-Week Non-Inferiority Study of Lurasidone and Risperidone for the Treatment of Schizophrenia.

A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia.

Prolactin Levels in Male Schizophrenic Patients Treated with Risperidone and Haloperidol: a Double-Blind and Randomized Study

THERAPEUTIC AND ADVERSE EFFECTS OF RISPERIDONE IN TREATMENT OF DIFFERENT GENDER PATIENTS WITH SCHIZOPHRENIA

Double-blind Comparison of Ziprasidone and Risperidone in the Treatment of Chinese Patients with Acute Exacerbation of Schizophrenia

Observation on Clinical Efficacy of Risperidone in Treatment of Children and Adolescents with Schizophrenia

Quetiapine and risperdal in the treatment of schizophrenia:an one-year follow up study.

Relationships between serum concentration and clinical effects in Han Chinese schizophrenia patients treated with risperidone

Serum Prolactin Levels, Plasma Risperidone Levels, Polymorphism of Cytochrome P450 2D6 and Clinical Response in Patients with Schizophrenia.